| |
|

August 2020 Vol. 8 No.8
Other viewing option
Abstract
Full text
Reprint (PDF) (120 KB)
Search Pubmed for articles by:
Papadopoulou
D
Hitoglou
A
Other links:
PubMed Citation
Related articles in PubMed
|
|
Merit Research Journal of Medicine and Medical
Sciences (ISSN: 2354-323X) Vol. 8(8) pp. 374-378,
August, 2020
Copyright © 2020 Author(s) retain the copyright
of this article
DOI: 10.5281/zenodo.3996275 |
|
Original Research Article
Research on the prevalence
of COX-2 gene promoter -765G>C polymorphism, inflammation, and
serum levels of PGE2
in coronary artery disease |
|
| |
| |
|
Dimitra Papadopoulou1,
Kali Makedou2*,
Antonios Ziakas3,
Anagnostis Argiriou4,
Amalia Boufidou3,
Stylianos Elemes1
and
Areti Hitoglou1 |
|
|
1Laboratory of Lipids and
Cardiovascular Disease Prevention, 2nd Pediatric Department,
AHEPA University Hospital, School of Medicine, Aristotle
University of Thessaloniki, Greece
2Laboratory of Biochemistry, AHEPA University
Hospital, School of Medicine, Aristotle University of
Thessaloniki, Greece
31st Department of Cardiology, AHEPA University
Hospital, School of Medicine, Aristotle University of
Thessaloniki, Greece
4Department of Food Science and Nutrition, University
of the Aegean, Greece
*Corresponding Author's E-mail: kmakedou@auth.gr
Tel.: +30 2310346942
Received: 31 July 2020 I Accepted: 14
August 2020
I Published: 24 August 2020 I Article ID:
MRJMMS-20-119
Copyright © 2020 Author(s) retain the
copyright of this article.
This article is published under the terms of the
Creative Commons Attribution
License 4.0. |
|
|
Abstract |
|
|
Cyclooxygenase-2
(COX-2) is an enzyme involved in the production of
prostaglandins during inflammation. The aim of this study was to
investigate the prevalence of COX-2 gene promoter -765G>C
polymorphism in a Greek adult population in relation to coronary
artery disease. In total, 102 subjects, 74 men (72.55%) and 28
women (27.45%) (median (range) 55 (36-86) years of age) were
recruited. Subjects were divided into two main groups: 69
patients (67.65%) hospitalized for myocardial infarction (MI),
54 (78.26%) of which with elevated ST (STEMI) and 15 (21.74%)
without (NSTEMI) (study group). The second group consisted of 33
patients (32.35%) with unstable angina but no history of MI
(controls). Serum levels of highly sensitive C-reactive protein
(hsCRP) and prostaglandin E2 (PGE2) and COX-2 -765G>C gene
promoter polymorphism were determined. Genotype frequencies were
60% for CC, 22% for GC and 18% for GG in the total of subjects
participating. Although there were statistically significant
higher hsCRP levels in study group than controls (p<0.001),
there were no significant differences in serum levels of hsCRP
(p=0.807 and 0.893) or PGE2
(p=0.455 and p=0.303) between different genotypes in either
group, respectively. The onset of acute coronary events does not
seem to be related to the -765GŕC
polymorphism of the COX-2 gene promoter.
Keywords: -765G>C, Acute coronary syndrome, COX-2,
Frequencies, Inflammation
|
|
|
|